01.09.2002 | Article
Concurrent paclitaxel-cisplatin and twice-a-day irradiation in stage IIIA and IIIB NSCLC shows improvement in local control and survival with acceptable hematologic toxicity
Erschienen in: Pathology & Oncology Research | Ausgabe 3/2002
Einloggen, um Zugang zu erhalten